(1)
Nitrosamine Impurities in Pharmaceutical Products: A Comprehensive Review of Sources, Analytical Detection Methods, Toxicological Risks, and Regulatory Guidelines: Nitrosamine Impurities in Pharmaceuticals: Sources, Detection, Risks, and Regulations. JDDB 2025, 2 (3), 23-42. https://doi.org/10.61920/3x6f8b82.